[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Editorial Board::
Executive Members::
Instruction to Authors::
Peer Review::
Articles Archive::
Indexing Databases::
Contact Us::
Site Facilities::
::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
:: Search published articles ::
Showing 1 results for O.Emadian (MD)

Zh.torabizade (md), F.naghshvar (md), O.emadian (md),
Volume 7, Issue 2 (Autumn & Winter 2005)
Abstract

Background&Objective: There are different methods including H&E, imonhistochemstry, flu cytometry, AgNOR staining for differentiation reactive hyperplasia from lymphoma. This study was done to determine diagnostic validity of AgNOR staining for differentating non-Hodgkin lymphoma from reactive hyperpalsia. Materials&Methods: Fifty parafin blocks belong to patients with confirmed diagnosis are as below: Thirty five block with lymphoma and fifteen blocks with reactive hyperplasia. AgNor dots among one hundred cells were counted, by two experienced pathologists. The mean of AgNOR dots were calculated. Student T-test used to campare mean AgNOR dots. Results: The mean AgNOR count was 2.2 (range 1.4-3, SD=0.8) in reactive hyperplasia and 6.7 (range 3.9-9.5, SD=2.8) in non-Hodgkin lymphoma. A statistically significant difference was observed between the AgNOR count of reactive hypeerplasia and non-Hodgkin lymphoma (p<0.05). Conclusion: The findings support the validity of AgNOR technique for differentiating and confirming non-Hodgkin lymphoma from reactive hyperplasia.

Page 1 from 1     

مجله دانشگاه علوم پزشکی گرگان Journal of Gorgan University of Medical Sciences
Persian site map - English site map - Created in 0.11 seconds with 23 queries by YEKTAWEB 4660
Creative Commons License
This work is licensed under a Creative Commons — Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)